ArticleJournal of orthopaedic case reports2025
Functional Outcomes of Surgical Treatment for Giant Cell Tumors around the Knee.
Article in Journal of orthopaedic case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Campanacci stage and cortical destruction predict functional outcomes in giant cell tumor of bone.Irish journal of medical science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Giant cell tumour (GCT) of bone is a rare, benign yet locally aggressive neoplasm that frequently involves the epiphyseal-metaphyseal regions of long bones, especially around the knee. Materials and Methods: This retrospective study evaluated 31 patients who underwent surgical treatment for GCT around the knee at a tertiary care center, with a minimum follow-up of 1 year. Patients were staged radiologically using Campanacci grading, with 11 Grade II and 20 Grade III tumors included. Treatment approaches involved extended curettage with sandwich procedures (polymethyl methacrylate cement), bone grafting (autologous or morselized allograft), and wide excision with endoprosthesis. Clinical outcomes were assessed using the Musculoskeletal Tumor Society (MSTS) score. The mean MSTS scores were 28.91 for the sandwich procedure, 29.28 for bone grafting, 26.33 for curettage with allograft, and 27.83 for endoprosthesis. Complications were minimal, with one local recurrence and no infections reported. Revision surgeries were required in two patients for non-recurrence-related complications. Postoperative rehabilitation emphasized early mobilization, with tailored weight-bearing protocols based on the reconstruction technique. Conclusion: This study highlights favorable outcomes across different surgical methods, emphasizing the utility of bone cement as an effective adjuvant in reducing recurrence rates. Limitations include the small sample size, retrospective nature, and lack of direct comparison across all methods.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.